Back to News
News

Madeira's Cancer Registry Publishes Groundbreaking Study

Madeira GuideMadeira Guide
January 16, 2026
2 min read

The Madeira Cancer Registry has achieved a landmark by publishing its first international peer-reviewed study, focusing on liver cancer etiology.

In a significant development for the Madeira health sector, the Madeira Cancer Registry (RO-RAM), part of the Health Service of the Autonomous Region of Madeira, has published its first scientific study in an international peer-reviewed journal. The study appeared in Cancer Epidemiology, a prestigious journal by Elsevier.

This pioneering research introduces a methodological approach that is the first of its kind in Europe, previously only developed in the United States. It focuses on analyzing the etiological profile of liver cancer in the Autonomous Region of Madeira. Liver cancer is noted as one of the most lethal types of tumors, making this study particularly important for both local and broader medical communities.

The implications of this study are significant, as it provides a new understanding of liver cancer causes in Madeira, potentially influencing future healthcare policies and cancer treatment strategies in the region. The research also highlights the growing capabilities of Madeira's health services in contributing to global scientific knowledge.

For Madeira residents and tourists, this development underscores the region's commitment to advancing healthcare and scientific research, enhancing Madeira's reputation as not only a top tourist destination but also a center for medical excellence.

Sources

Madeira Guide

Madeira Guide

Author